Xtant Medical Holdings Inc (XTNT): Five investment analysts have rated the...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	1053
Posts	189434
Boards Moderated	1
Alias Born	06/19/2009

ash111

Re: ash111 post# 13

Wednesday, 01/11/2017 9:46:12 AM

Wednesday, January 11, 2017 9:46:12 AM

Five investment analysts have rated the stock with a buy rating, The company has a consensus rating of Buy and a consensus price target of $4.45. today's numbers confirmed it. clear and simple.

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent XTNT News

Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/12/2024 04:15:07 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2024 09:12:23 PM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/04/2024 01:45:46 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/03/2024 09:09:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:05:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 09:01:54 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:40:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:26:41 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:14:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:09:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:30:20 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:25:30 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:20:37 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 08:15:31 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/10/2024 11:00:27 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:20:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:15:42 PM
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds • GlobeNewswire Inc. • 04/30/2024 09:00:00 AM
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million • GlobeNewswire Inc. • 04/01/2024 11:00:00 AM
Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024 • GlobeNewswire Inc. • 03/21/2024 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:13:22 PM
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM

More XTNT News

InvestorsHub NewsWire

VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM

Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM

HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM

Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM

Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM

PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover